Physician
Endocrinology
Dr. Ariel L. Barkan, MD
|
|
Give Review
Ariel L. Barkan is an expert in the field of Endocrinology. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Doctor Ariel L. Barkan, MD is also a published doctor. He has 99 paper published. The most recent paper is: Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years.
- Ectopic Prolactin Secretion From a Perivascular Epithelioid Cell Tumor (PEComa).
- Growth hormone should be used only for approved indications.
- Pharmacological treatment of Acromegaly: its place in the overall therapeutic approach.
- Tamoxifen as a therapeutic agent in Acromegaly.
- Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with Acromegaly: further evidence for a present hypothalamic control of pi...
- Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid Metabolism.
- Pituitary carcinoma With endolymphatic sac metastasis.
- Repeat endoscopic transsphenoidal surgery for Acromegaly: remission and complications.
- Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular Disease risk.
- Rapid suppression of Growth hormone concentration by overeating: potential mediation by hyperinsulinemia.
- Clinical problem solving: monster on the hook--case problems in neurosurgery.
- Basal, but not pulsatile, Growth hormone secretion determines the ambient circulating levels of insulin-like Growth factor-I.
- The pattern of Growth hormone delivery to peripheral tissues determines insulin-like Growth factor-1 and lipolytic responses in obese subjects.
- Treatment of pituitary tumors: a surgical perspective.
- Current diagnosis of Acromegaly.
- Defining normalcy of the somatotropic axis: an attainable goal?
- The role of endogenous growth hormone-releasing hormone in Acromegaly.
- Complex rhythmicity of Growth hormone secretion in humans.
- Glucose homeostasis and safety in patients with Acromegaly converted from long-acting octreotide to pegvisomant.
- Effects of dietary carbohydrate restriction with high protein intake on protein Metabolism and the somatotropic axis.
- Alterations in carbohydrate Metabolism in response to short-term dietary carbohydrate restriction.
- Endogenous circulating ghrelin does not mediate Growth hormone rhythmicity or response to fasting.
- Clinically silent somatotropinomas may be biochemically active.
- Growth hormone/insulin-like Growth factor-I system and connective tissues: basic aspects and clinical implications.
- GH receptor antagonist: mechanism of action and clinical utility.
- The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.
- Physiological testosterone replenishment in healthy elderly men does not normalize pituitary Growth hormone output: evidence against the connection between senile hypo...
- Augmentation of growth hormone secretion after testosterone treatment in boys With constitutional delay of growth and adolescence: evidence against an increase in hypo...
- Sexual dimorphism of Growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men.
- Pulsatile and nocturnal Growth hormone secretions in men do not require periodic declines of somatostatin.
- Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient Growth hormone levels.
- Somatostatin analogs in medical treatment of Acromegaly.
- Management options for persistent functional tumors.
- Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
- Medical management of Growth hormone-secreting pituitary adenomas.
- Current status and future opportunities for controlling Acromegaly.
- In vivo Investigation of Hypothalamic Secretory Activity.
- Both VP2 and VP3 are synthesized from each of the alternative spliced late 19S RNA species of simian virus 40.
- Isolated gonadotrope failure in the polyglandular autoimmune Syndrome.
- Opioids modulate pituitary receptors for gonadotropin-releasing Hormone.
- The frequency of gonadotropin-releasing Hormone stimulation determines the number of pituitary gonadotropin-releasing Hormone receptors.
- Liver diseases and cancer associated with lack of lymphocytic cortisol Metabolism enhancing factor.
- Detection of cancer in patients by reduced lymphocytic cortisol Metabolism-enhancing effect.
- Kallman''s Syndrome:is it always for life.
- Primary hyperparaThyroidism: possible cause of primary hyperaldosteronism in a 60-year-old woman.
- Decreased hypothalamic gonadotropin-releasing Hormone secretion in male marathon runners.
- When the light turns blue.
- Opioid and neurotransmitter regulation of pituitary gonadotropin-releasing Hormone (GnRH) receptors in the ovariectomized estradiol-treated rat: role of altered GnRH s...
- HypoThyroidism with spontaneous progression to hyperThyroidism.
- Hyperprolactinemia inhibits gonadotropin-releasing Hormone (GnRH) stimulation of the number of pituitary GnRH receptors.
- Pituitary gonadotropin-releasing Hormone receptors during gonadotropin surges in ovariectomized-estradiol-treated rats.
- Regulation of pituitary gonadotropin-releasing Hormone (GnRH) receptors by pulsatile GnRH in female rats: effects of estradiol and prolactin.
- Gonadal regulation of pituitary gonadotropin-releasing Hormone receptors during sexual maturation in the rat.
- Ectopic prolactinoma in a patient with hyperparathyroidism and Abnormal sellar radiography.
- Calcification of auricular cartilages in patients With hypopituitarism.
- Pituitary atrophy in patients with Sheehan's Syndrome.
- Dexamethasone alters responses of pituitary gonadotropin-releasing Hormone (GnRH) receptors, gonadotropin subunit messenger ribonucleic acids, and gonadotropins to pul...
- Acromegalic arthropathy and sleep apnea.
- LH subunit mRNA concentrations during LH surge in ovariectomized estradiol-replaced rats.
- Acromegalic arthropathy. Characteristics and response to therapy.
- Regulation by oestradiol of serum levels of LH and FSH and pituitary levels of gonadotrophin-releasing Hormone receptors after ovariectomy in the rat.
- Somatostatin receptor scintigraphy of a patient With a giant invasive prolactinoma.
- Bone mineral density of the axial skeleton in Acromegaly.
- Scintigraphic localization of ovarian dysfunction.
- New options for diagnosing and treating Acromegaly.
- Gonadotrophin responses to GnRH pulses in hypogonadotrophic hypogonadism: LH responsiveness is maintained in the presence of luteal phase concentrations of oestrogen a...
- Acromegaly. Diagnosis and therapy.
- Growth hormone therapy for hypopituitary adults: time for re-appraisal.
- Dexamethasone suppresses gonadotropin-releasing Hormone (GnRH) secretion and has direct pituitary effects in male rats: differential regulation of GnRH receptor and go...
- Idiopathic hypogonadotropic hypogonadism in men: dependence of the Hormone responses to gonadotropin-releasing Hormone (GnRH) on the magnitude of the endogenous GnRH s...
- Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
- Rapid reduction of left ventricular hypertrophy in Acromegaly after suppression of growth hormone hypersecretion.
- Dynamic changes of growth hormone-binding protein concentrations in normal men and patients with Acromegaly: effects of short-term fasting.
- Criteria for cure of Acromegaly: a consensus statement.
- Somatostatin Withdrawal alone is an ineffective generator of pulsatile growth hormone release in man.
- Ontogeny of GH mRNA and GH secretion in male and female rats: regulation by GH-releasing Hormone.
- Acromegalic arthropathy.
- Plasma Growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity.
- Fasting-induced changes in Thyroid hormone economy in normal and acromegalic subjects.
- Guidelines for the treatment of Growth hormone excess and Growth hormone deficiency in adults.
- Effect of chronic octreotide treatment on intestinal absorption in patients with Acromegaly.
- Regulation of somatic Growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like Growth factor I gene expression and secretion.
- Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans.
- Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-...
- Growth hormone secretory dynamics over the menstrual cycle.
- Acromegaly. Recognition and treatment.
- Pituitary Disorders. Drug treatment options.
- Treatment of Acromegaly with the growth hormone-receptor antagonist pegvisomant.
- Long-term treatment of Acromegaly with pegvisomant, a growth hormone receptor antagonist.
- Hormonal responses to short term fasting in postmenopausal women.
- Effect of carbohydrate supplementation on reproductive Hormones during fasting in men.
- Increased growth hormone pulse frequency in Acromegaly.
- The "quality of life-assessment of Growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?
- Induction of Growth hormone (GH) mRNA by pulsatile GH-releasing hormone in rats is pattern specific.
- Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry.
- The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in Acromegaly.
- Evaluation of the integrity of the hypothalamic-pituitary-Adrenal axis by insulin hypoglycemia test.
Schools
MINSKIJ MEDICAL INSTITUTE
Beilinson Med Center
University Of Michigan
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
University of Michigan Hospitals and Health Centers -
Minsk Medical Institute
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1891877320 | |
| NPPES Provider LastName | BARKAN | |
| NPPES Provider FirstName | ARIEL | |
| NPPES Provider ZIPCode | 481095366 | |
| NPPES Provider State | MI | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 266.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891877320 |
| Last Name Of The Provider | BARKAN |
| First Name Of The Provider | ARIEL |
| View All |
Similar Doctors
|
|
Dr. Peter Arvan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Urbanic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger J. Grekin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela R. Subauste, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saadia R. Mian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elif Oral, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Wyckoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer R. Franzese, MD
This Doctor is OpenDoctor Recommended.
|